Dr. Nils Morgenthaler studied medicine at the University of Ulm and wrote his academic thesis in endocrinology. He completed his training at the university hospitals of Ulm and Leipzig, and at King’s College Hospital in London, specializing in internal medicine.
He left clinical medicine in 1997 to work for BRAHMS GmbH and played a key role in bringing novel in vitro diagnostic assays from bench to bedside, including TSH-receptor autoantibodies, Procalcitonin and Copeptin. After getting an executive MBA from the University of Potsdam, he became General Manager for GILUPI GmbH, and subsequently, Vice President for Clinical Business Development at BRUKER Daltonics in Bremen. He joined InVivo Biotech Services as General Manager in 2017.
Dr. Morgenthaler has more than 20 years of management experience in the diagnostic industry, and a long track record of research collaborations, with over 200 scientific publications covering the fields of endocrinology/diabetes, infectious diseases/sepsis, cardiology and oncology.

Julia completed her studies in 2010 as a biologist at the Freie Universität Berlin with a focus on genetics and molecular biology. During her doctoral thesis at the Max-Planck-Institute for molecular genetics she worked with DNA-encoded chemical libraries. She joined InVivo in 2015 and has worked both in the R&D Department and in Sales & Customer Service. In her present role as employee of Customer Service and Sales team, Julia is in-charge of key customers and new acquisitions in the DACH Region. Apart from customers, she also handles an umbrella of responsibilities under marketing as well as internal processes.